BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lam RA, Tien TZ, Joseph CR, Lim JX, Thike AA, Iqbal J, Tan PH, Yeong JPS. Cancer-Testis Antigens in Triple-Negative Breast Cancer: Role and Potential Utility in Clinical Practice. Cancers (Basel) 2021;13:3875. [PMID: 34359776 DOI: 10.3390/cancers13153875] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Hoyos V, Vasileiou S, Kuvalekar M, Watanabe A, Tzannou I, Velazquez Y, French-Kim M, Leung W, Lulla S, Robertson C, Foreman C, Wang T, Bulsara S, Lapteva N, Grilley B, Ellis M, Osborne CK, Coscio A, Nangia J, Heslop HE, Rooney CM, Vera JF, Lulla P, Rimawi M, Leen AM. Multi-antigen-targeted T-cell therapy to treat patients with relapsed/refractory breast cancer. Ther Adv Med Oncol 2022;14:17588359221107113. [PMID: 35860837 DOI: 10.1177/17588359221107113] [Reference Citation Analysis]
2 Bai R, Yuan C. Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1): A Promising Cancer Testis Antigen. Aging Dis 2022;13:1267-77. [PMID: 35855340 DOI: 10.14336/AD.2021.1207] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]